Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 23:18:03 GMT 2025
by
admin
on
Mon Mar 31 23:18:03 GMT 2025
|
| Protein Sub Type | |
| Sequence Type | COMPLETE |
| Record UNII |
J5LT149M79
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
820721
Created by
admin on Mon Mar 31 23:18:03 GMT 2025 , Edited by admin on Mon Mar 31 23:18:03 GMT 2025
|
||
|
FDA ORPHAN DRUG |
837721
Created by
admin on Mon Mar 31 23:18:03 GMT 2025 , Edited by admin on Mon Mar 31 23:18:03 GMT 2025
|
||
|
FDA ORPHAN DRUG |
377612
Created by
admin on Mon Mar 31 23:18:03 GMT 2025 , Edited by admin on Mon Mar 31 23:18:03 GMT 2025
|
||
|
EU-Orphan Drug |
EU/3/19/2151
Created by
admin on Mon Mar 31 23:18:03 GMT 2025 , Edited by admin on Mon Mar 31 23:18:03 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DB15278
Created by
admin on Mon Mar 31 23:18:03 GMT 2025 , Edited by admin on Mon Mar 31 23:18:03 GMT 2025
|
PRIMARY | |||
|
1600492-21-4
Created by
admin on Mon Mar 31 23:18:03 GMT 2025 , Edited by admin on Mon Mar 31 23:18:03 GMT 2025
|
PRIMARY | |||
|
C170152
Created by
admin on Mon Mar 31 23:18:03 GMT 2025 , Edited by admin on Mon Mar 31 23:18:03 GMT 2025
|
PRIMARY | |||
|
10157
Created by
admin on Mon Mar 31 23:18:03 GMT 2025 , Edited by admin on Mon Mar 31 23:18:03 GMT 2025
|
PRIMARY | |||
|
J5LT149M79
Created by
admin on Mon Mar 31 23:18:03 GMT 2025 , Edited by admin on Mon Mar 31 23:18:03 GMT 2025
|
PRIMARY | |||
|
100000177205
Created by
admin on Mon Mar 31 23:18:03 GMT 2025 , Edited by admin on Mon Mar 31 23:18:03 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_7 | 1_12 |
| 1_26 | 1_42 |
| 1_110 | 2_135 |
| 1_158 | 1_177 |
| 1_188 | 1_216 |
| 2_17 | 2_22 |
| 2_50 | 2_61 |
| 2_55 | 2_70 |
| 2_72 | 2_81 |
| 2_91 | 2_102 |
| 2_98 | 2_112 |
| 2_114 | 2_127 |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_170 |
| N | 2_128 |
| N | 2_145 |
| O | 2_52 |
| O | 2_60 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| FRAGMENT | [2_63] | D | .BETA.-HYDROXY-L-ASPARTIC ACID, ERYTHRO- | GDV0MSK2SG | ||
| FRAGMENT | [2_6] [2_7] [2_14] [2_16] [2_19] [2_20] [2_25] [2_26] [2_29] [2_35] | E | .GAMMA.-CARBOXYGLUTAMIC ACID | 16FQV4RZKL |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
| Molecular Formula | CHEMICAL |
|